Profile photo Birgit Lissenberg-Witte

Birgit Lissenberg-Witte

Assistant Professor

Biography

I am an assistant professor and biostatistician working at the Clinical Trial Methodology and Statistical Consultation Team within the Department of Data Science and Biostatistics of the Julius Center. My interests lie in survival outcomes, quality of life questionaires and innovatice clinical trial methodology, mainly focusing on oncological diseases (mainly head and neck cancer, colorectal cancer and hematology).  I also collaborate with researchers from other disciplines  to design, conduct and analyze clinical research.

Before I joined the UMC Utrecht, I worked at the VU University Medical Center (VUmc; later Amsterdam UMC – location VUmc) as a biostatistician, providing methodological and statistical consultancy for clinical researchers and a methodologist of the Medical Ethical Review Board.

I hold a PhD degree in Mathematical Statistics from the Delft University of Technology (2011) and a MSc degree in Mathematics from the VU University Amsterdam (2005).

Recent publications

Circulating tumour DNA in patients with stage III colon cancer Carmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken, Haoyue Wang, Sietske C M W van Nassau, Suzanna J Schraa, Dave E W van der Kruijssen, Karlijn van Rooijen, Theodora C Linders, Pien Delis-van Diemen, Maartje Alkemade, Anne Bolijn, Marianne Tijssen, Margriet Lemmens, Lana Meiqari, Steven L C Ketelaars, Adria Closa-Mosquera, Miranda M W van Dongen, Mirthe Lanfermeijer, Birgit I Lissenberg-Witte, Linda J W Bosch, Teunise Bisschop-Snetselaar, Bregje C Adriaans, Amy Greer, David Riley, James R White, Christopher Greco, Liam Cox, Jesse Fox, Kaitlin Victor, Catherine Leech, Samuel V Angiuoli, Niels F M Kok, Cornelis J A Punt, Daan van den Broek, Miriam Koopman, Gerrit A Meijer, Victor E Velculescu, Jeanine M L Roodhart, Veerle M H Coupé, Mark Sausen, Geraldine R Vink, Remond J A Fijneman,
The British journal of surgery, 2026, vol. 113
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis Lisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, Josephine S Michelsen, Einar A Høgestøl, Kjell-Morten Myhr, Henning H Rise, Zehao Su, Frank Eriksson, Tim Friede, Henrik Lundell, Finn Sellebjerg, Karam Sidaros, Hartwig Roman Siebner, Vanessa Wiggermann, Bas Jasperse, Birgit Lissenberg-Witte, Bob W van Oosten, Menno M Schoonheim, Gilles Edan, Malo Gaubert, Emmanuelle Le Page, Anne Kerbrat, Laure Michel, Eva M M Strijbis, Øivind Torkildsen, Jeppe Romme Christensen
Multiple Sclerosis and Related Disorders, 2025, vol. 105
Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia Femke V M Mulder, Anne-Marie L Becking, Sophie J Bernelot Moens, Marit Jalink, Dorothea Evers, Liane Te Boome, Anouk Breedijk, Jolanda Droogendijk, René van der Griend, Koen de Heer, Anja B U Mäkelburg, Caroline M P W Mandigers, Laurens Nieuwenhuizen, Rimke Oostvogels, J F M Hans Pruijt, Josien Regelink, Josien Rozenberg, Leonie Strobbe, Fleur M van der Valk, Birgit I Lissenberg-Witte, Josephine M I Vos
British Journal of Haematology, 2025, vol. 207, p.2653-2658
Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice Ilias Houda, Dwayne Naves, Ezgi B Ulas, Birgit I Lissenberg-Witte, Nicole P Barlo, Elisabeth A Kastelijn, Hicham Bouhaddou, Rimsha Shaikh, Chris Dickhoff, Teodora Radonic, Famke L Schneiders, Suresh Senan, Ronald A M Damhuis, Idris Bahce
European Journal of Cancer, 2025, vol. 230
Evaluating the significance of combining PD-L1 and TILs as biomarkers in non-small cell lung cancer patients treated with immunotherapy Y Derraze, S M S Hashemi, E B Ulas, K A Ziesemer, B Lissenberg-Witte, T Radonic, I Bahce
BJC reports, 2025, vol. 3
Supportive Care Needs From Mid-to Long-Term Follow-Up Among Head and Neck Cancer Survivors Femke Jansen, Dominique Molenaar, Öykü Zarsat, Birgit I Lissenberg-Witte, Robert P Takes, Remco de Bree, Johannes A Langendijk, Jose A Hardillo, Femke Lamers, C René Leemans, Irma M Verdonck-de Leeuw
Psycho-oncology, 2025, vol. 34